Medication info
Glyance Tablet 25 mg (Empagliflozin)

Glyance Tablet 25 mg (Empagliflozin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin Amorphous›25mg / 1 tablet
Manufacturer / importer
International Pharmaceutical Co., Ltd.
Appearance
Pale yellow, oval-shaped, biconvex film-coated tablet
Packaging
30 tablets/box [(*10 tablets/PTP*3)]
Approval status
Active

MFDS item code 202101826 · Approved 2021.02.24 · Insurance code 643705620

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment No dose adjustment is required for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistent glomerular filtration rate below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those undergoing dialysis, as efficacy is not expected. •Patients with hepatic impairment No dose adjustment is required for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. •Older adults No dose adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of treatment with this medicine is not recommended in adults aged 85 years or older because clinical experience is limited (see Precautions for Use, 4. General Precautions)

Ingredients

Manufacturer
International Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • dysregulation of blood sugar
  • cardiovascular disease
View approved original text

This medication aids in blood sugar control for adult patients with type 2 diabetes by supporting dietary and exercise therapies. It can be taken alone or used in combination with other medications. Caution is indicated for type 2 diabetes patients with cardiovascular disease who are not achieving sufficient blood sugar control, due to the risk of cardiovascular events. Therefore, this medication is used to improve blood sugar control in diabetic patients.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment No dose adjustment is required for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistent glomerular filtration rate below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those undergoing dialysis, as efficacy is not expected. •Patients with hepatic impairment No dose adjustment is required for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. •Older adults No dose adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of treatment with this medicine is not recommended in adults aged 85 years or older because clinical experience is limited (see Precautions for Use, 4. General Precautions)

Precautions

This medication should not be used in patients who are hypersensitive to the active substance or any excipients. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. It is contraindicated in patients with severely impaired kidney function, i.e., those with a glomerular filtration rate (GFR) of less than 30 mL/min/1.73m², those with end-stage renal disease, or those undergoing dialysis. This drug contains lactose and should not be given to patients with inherited conditions such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Caution should be exercised when using this medication in patients with slightly impaired kidney function, and especially in those with a GFR of less than 60 mL/min/1.73m², where dose adjustment or discontinuation may be necessary. It is recommended to use with caution in patients with heart failure classified as NYHA class I-II, and it should not be used in patients classified as class III-IV. There is an increased risk of hypoglycemia when taken with medications like insulin or sulfonylureas, so dosage adjustments may be necessary. This medication can cause various adverse effects, including hypoglycemia, genital infections, increased urination, urinary tract infections, and decreased blood volume, so symptoms should be monitored closely. A serious metabolic acidosis called ketoacidosis may occur, so if symptoms like vomiting, abdominal pain, or dyspnea appear, immediate consultation with a healthcare professional is required. Elderly patients or those at high risk of dehydration or hypotension should be monitored for dehydration or low blood pressure and may need to temporarily discontinue the medication if necessary. Serious urinary infections such as urosepsis or pyelonephritis can occur, so rapid treatment is required upon the onset of infection symptoms. There is also an increased risk of genital fungal infections with this medication, so patients with a history of such infections should be particularly cautious. Caution is advised when driving or operating machinery due to the risk of hypoglycemia, especially when used in conjunction with insulin. The use of this medication is not recommended during pregnancy, and it should be discontinued immediately if pregnancy is confirmed. If breastfeeding, it is advisable to discontinue nursing as this medication may be excreted in breast milk. Its safety and efficacy have not been established for patients under 18 years of age, so it should not be used. No specific toxic reactions have been reported in cases of overdose, but appropriate treatment is necessary depending on the clinical condition. This medication should be stored out of reach of children and care should be taken not to transfer it to other containers as this may compromise its quality.

Side effects

  • Hypoglycemia
  • vulvar dysplasia
  • vulvovaginitis
  • balanitis
  • other genital infections
  • increased urination
  • urinary tract infection
  • decreased fluid volume
  • dehydration
  • hypotension
Show 203 more
  • decreased blood volume
  • orthostatic hypotension
  • syncope
  • increased serum creatinine
  • decreased glomerular filtration rate
  • ketoacidosis
  • rash
  • urticaria
  • angioedema
  • perineal necrosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • colon bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • salpingeal-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureteral stone disease
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • low back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • operculated retinal detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternal fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the Vater ampulla
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic adenocarcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • epigastric pain
  • dental caries
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distention
  • anal bleeding
  • chronic gastritis
  • enteritis
  • flatulence
  • gastric polyp
  • gingival swelling
  • bloody stools
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • dyspepsia
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • paronychia
  • superficial mycosis
  • dental abscess
  • nasopharyngitis
  • positional dizziness
  • sensory impairment
  • perceptual disturbance
  • amnesia
  • diabetic neuropathy
  • facial paralysis
  • abnormal memory
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • drowsiness
  • fatigue
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • chills
  • strange sensations
  • edema
  • pain
  • puncture site pain
  • weight gain
  • ECG abnormalities
  • decreased hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • decreased appetite
  • hypersomnia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • conjunctival congestion
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • age-related dyspnea
  • wet cough
  • allergic rhinitis
  • cough
  • skin laceration
  • bruise
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • anxiety
  • depression
  • sleep disorder
  • ear pain
  • positional vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetes mellitus
  • diabetic retinopathy
  • dry eyes
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is best kept at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the drug's efficacy and ensures safe use.

Appearance and packaging

Appearance

Pale yellow, oval-shaped, biconvex film-coated tablet

Package unit

30 tablets/box [(*10 tablets/PTP*3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.